Literature DB >> 8090178

Methylene blue in the hepatopulmonary syndrome.

G Rolla, C Bucca, L Brussino.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8090178     DOI: 10.1056/NEJM199410203311617

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

1.  Cardiopulmonary effects of nitric oxide inhalation and methylene blue injection in hepatopulmonary syndrome.

Authors:  V Jounieaux; O Leleu; I Mayeux
Journal:  Intensive Care Med       Date:  2001-06       Impact factor: 17.440

Review 2.  Hepatopulmonary syndrome.

Authors:  M B Fallon; G A Abrams
Journal:  Curr Gastroenterol Rep       Date:  2000-02

Review 3.  Hepatopulmonary syndrome: What we know and what we would like to know.

Authors:  Israel Grilo-Bensusan; Juan Manuel Pascasio-Acevedo
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

4.  Effects of nitric oxide inhibition by methylene blue in cirrhotic patients with ascites.

Authors:  Georgios Kalambokis; Michalis Economou; Andreas Fotopoulos; Jihad Al Bokharhii; Pappas Christos; Kosta Paraskevi; Papadimitriou Konstantinos; Afroditi Katsaraki; Epameinondas V Tsianos
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

5.  The role of receptor tyrosine kinase activation in cholangiocytes and pulmonary vascular endothelium in experimental hepatopulmonary syndrome.

Authors:  Wenli Yang; Junlan Zhang; Bingqian Hu; Wei Wu; Julie Venter; Gianfranco Alpini; Michael B Fallon
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-11-07       Impact factor: 4.052

Review 6.  Hepatopulmonary Syndrome.

Authors:  Yong Lv; Daiming Fan
Journal:  Dig Dis Sci       Date:  2015-03-03       Impact factor: 3.199

Review 7.  Medical management of chronic liver diseases (CLD) in children (part II): focus on the complications of CLD, and CLD that require special considerations.

Authors:  Mortada H F El-Shabrawi; Naglaa M Kamal
Journal:  Paediatr Drugs       Date:  2011-12-01       Impact factor: 3.022

Review 8.  Hepatopulmonary syndrome: update on pathogenesis and clinical features.

Authors:  Junlan Zhang; Michael B Fallon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-03       Impact factor: 46.802

9.  Intestinal endotoxemia plays a central role in development of hepatopulmonary syndrome in a cirrhotic rat model induced by multiple pathogenic factors.

Authors:  Hui Ying Zhang; De Wu Han; Ai Rong Su; Li Tong Zhang; Zhong Fu Zhao; Jing Quan Ji; Bao Hong Li; Cheng Ji
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

Review 10.  Cardiovascular changes in cirrhosis: pathogenesis and clinical implications.

Authors:  Waleed K Al-Hamoudi
Journal:  Saudi J Gastroenterol       Date:  2010 Jul-Sep       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.